EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 4.0

Comparative Targeted Genome Profiling between Solid and Liquid Biopsies in Gastroenteropancreatic Neuroendocrine Neoplasms: A Proof-of-Concept Pilot Study

Irene Gagliardi, Federica Campolo, Patricia Borges de Souza, Lucrezia Rossi, Manuela Albertelli, Federica Grillo, Luigi Caputi, Massimiliano Mazza, Antongiulio Faggiano, Maria Chiara Zatelli

Neuroendocrinology · 2024

DOI: 10.1159/000541346 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Neuroendocrinology, 2024. Verfasst von Irene Gagliardi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Section of Endocrinology and Internal Medicine, Department of Medical Sciences, University of Ferrara, Ferrara, Italy. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Neuroendocrine Tumors, Stomach Neoplasms, Intestinal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Clinical presentation and genetic profile of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are highly variable, hampering their management. Sequencing of circulating tumor DNA from liquid biopsy (LB) has been proposed as a less invasive alternative to solid biopsy (SB). Our aim was to compare the mutational profile (MP) provided by LB with that deriving from SB in GEP-NETs.

Methods

SB and LB were derived simultaneously from 6 GEP-NET patients. A comparative targeted next-generation sequencing (NGS) analysis was performed on DNA from SB and LB to evaluate the mutational status of 11 genes (MEN1, DAXX, ATRX, MUTYH, SETD2, DEPDC5, TSC2, ARID1A, CHECK2, MTOR, and PTEN).

Results

Patients (M:F = 2:1; median age 64 years) included 3 with pancreatic and 3 with ileal NETs. NGS detected a median number of 55 variants/sample in SB and 66.5 variants/sample in LB specimens (mutational burden: 0.2–1.9 and 0.3–1.8 mut/Mb, respectively). Missense and nonsense mutations were prevalent in both, mainly represented by C>T transitions. ARID1A, MTOR, and ATRX were consistently mutated in SB, and ARID1A, TSC2, MEN1, PTEN, SETD2, and MUTYH were consistently mutated in LB. DAXX mutations were absent in LB. Seventeen recurrent mutations were shared between SB and LB; in particular, MTOR single-nucleotide variants c.G4731A and c.C2997T were shared by 5 out of 6 patients. Hierarchical clustering supported genetic similarity between SB and LB.

Conclusions

This pilot study explores the applicability of LB in GEP-NET MP evaluation. Further studies with larger cohorts are needed to validate LB and to define the clinical impact.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsNeuroendocrine TumorsStomach NeoplasmsIntestinal NeoplasmsHumansPilot ProjectsMaleFemaleMiddle AgedAgedLiquid BiopsyHigh-Throughput Nucleotide SequencingBiopsyProof of Concept StudyMutationAdult

Stichwörter der Autor:innen

Circulating tumor DNAGastroenteropancreatic neuroendocrine tumorGenome profilingLiquid biopsy

Autor:innen und Institutionen

  • Section of Endocrinology and Internal Medicine, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
  • Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
  • IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
  • Endocrinology, Department of Internal Medicine and Medical Specialties (DiMI), University of Genova, Genova, Italy.
  • Endocrinology Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Anatomic Pathology, Department of Surgical Sciences and Integrated Diagnostics (DISC), University of Genova, Genova, Italy.

Zitieren

APA

Gagliardi, I., Campolo, F., Borges de Souza, P., Rossi, L., Albertelli, M., Grillo, F., Caputi, L., Mazza, M., Faggiano, A., & Zatelli, M. C. (2024). Comparative Targeted Genome Profiling between Solid and Liquid Biopsies in Gastroenteropancreatic Neuroendocrine Neoplasms: A Proof-of-Concept Pilot Study. Neuroendocrinology. https://doi.org/10.1159/000541346

Vancouver

Gagliardi I, Campolo F, Borges de Souza P, Rossi L, Albertelli M, Grillo F, et al. Comparative Targeted Genome Profiling between Solid and Liquid Biopsies in Gastroenteropancreatic Neuroendocrine Neoplasms: A Proof-of-Concept Pilot Study. Neuroendocrinology. 2024. doi:10.1159/000541346

BibTeX
@article{Gagliardi2024,
  author = {Gagliardi, Irene and Campolo, Federica and Borges de Souza, Patricia and Rossi, Lucrezia and Albertelli, Manuela and Grillo, Federica and Caputi, Luigi and Mazza, Massimiliano and Faggiano, Antongiulio and Zatelli, Maria Chiara},
  title = {Comparative Targeted Genome Profiling between Solid and Liquid Biopsies in Gastroenteropancreatic Neuroendocrine Neoplasms: A Proof-of-Concept Pilot Study},
  journal = {Neuroendocrinology},
  year = {2024},
  doi = {10.1159/000541346}
}
Kostenlos starten →